TRIFORMIS RESILIA Tricuspid Valve, Model 11300T
Edwards Lifesciences, LLC · Decision date Feb 6, 2026
What did the FDA approve?
FDA records P150048/S097 as a supplement to PMA P150048, with the supplement type “Normal 180 Day Track No User Fee”. The recorded decision is approval, dated Feb 6, 2026.
FDA approval order statement
Approval of the protocol for the post-approval study (PAS) titled "EHR-Based New Enrollment Study." The PAS protocol was submitted to comply with the conditions of approval outlined in the approval order for P150048/S092.
- Regulatory pathway
- PMA supplement
- Supplement type
- Normal 180 Day Track No User Fee
- Clinical specialty
- Cardiovascular
- Decision date
- Feb 6, 2026
- FDA change category
- Postapproval Study Protocol
Regulatory record facts
- Identifier
- P150048/S097
- Regulatory pathway
- PMA supplement
- Applicant
- Edwards Lifesciences, LLC
- Product code
- LWR
- Decision code
- APPR
- Decision date
- Feb 6, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: heart-valve, non-allograft tissue.
- Applicant
- Edwards Lifesciences, LLC
- Product code
- LWR
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P150048. Subsequent supplements may change the device or its indications.
FDA decision timeline
P150048 · Original PMA
EDWARDS PERICARDIAL AORTIC BIOPROSTHESIS (MODEL 11000A) and EDWARDS INSPIRIS RESILIA AORTIC VALVE (MODEL 11500)
P150048/S093 · Related supplement
INSPIRIS RESILIA Aortic Valve; MITRIS RESILIA Mitral Valve
P150048/S092 · Related supplement
TRIFORMIS RESILIA Tricuspid Valve
P150048/S095 · Related supplement
Edwards INSPIRIS RESILIA Aortic Valve, Model 11500A, Sizes 19mm, 21mm, 23mm, 25mm, 27mm, and 29mm; Edwards KONECT RESILI
P150048/S097 received
Application receipt date recorded by FDA.
P150048/S096 · Related supplement
TRIFORMIS RESILIA Tricuspid Valve, Model 11300T
P150048/S097 · FDA decision
Normal 180 Day Track No User Fee
P150048/S098 · Related supplement
INSPIRIS RESILIA Aortic Valve; KONECT RESILIA Aortic Valve Conduit (AVC); MITRIS RESILIA Mitral Valve
P150048/S099 · Related supplement
INSPIRIS RESILIA Aortic Valve, MITRIS RESILIA Mitral Valve, KONECT RESILIA Aortic Valved Conduit
P150048/S094 · Related supplement
TRIFORMIS RESILIA Tricuspid Valve, Model 11300T Available in sizes: 25, 27, 29, 31 and 33 mm
P150048/S101 · Related supplement
INSPIRIS RESILIA Aortic Valve
P150048/S103 · Related supplement
EINSPIRIS RESILIA Aortic Valve, Model 11500A; KONECT RESILIA Aortic Valved Conduit (AVC), Model 11060A
P150048/S100 · Related supplement
INSPIRIS RESILIA Aortic Valve; MITRIS RESILIA Mitral Valve
P150048/S104 · Related supplement
INSPIRIS RESILIA Aortic Valve (11500A), KONECT RESILIA Aortic Valve Conduit (AVC) (11060A), MITRIS RESILIA Mitral Valv
Timeline entries are records held by MedtechLedger for P150048. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P150048
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Edwards Lifesciences, LLC | PMA approval | Jun 29, 2017 | FDA | |
| Edwards Lifesciences, LLC | PMA supplement | Oct 16, 2025 | FDA | |
TRIFORMIS RESILIA Tricuspid ValveP150048/S092 | Edwards Lifesciences, LLC | PMA supplement | Oct 27, 2025 | FDA |
| Edwards Lifesciences, LLC | PMA supplement | Dec 17, 2025 | FDA | |
TRIFORMIS RESILIA Tricuspid Valve, Model 11300TP150048/S096 | Edwards Lifesciences, LLC | PMA supplement | Feb 6, 2026 | FDA |
| Edwards Lifesciences, LLC | PMA supplement | Mar 11, 2026 | FDA | |
| Edwards Lifesciences, LLC | PMA supplement | Apr 16, 2026 | FDA | |
| Edwards Lifesciences, LLC | PMA supplement | May 26, 2026 | FDA | |
INSPIRIS RESILIA Aortic ValveP150048/S101 | Edwards Lifesciences, LLC | PMA supplement | Jun 3, 2026 | FDA |
| Edwards Lifesciences, LLC | PMA supplement | Jul 29, 2026 | FDA | |
| Edwards Lifesciences, LLC | PMA supplement | Oct 22, 2026 | FDA | |
| Edwards Lifesciences, LLC | PMA supplement | Oct 28, 2026 | FDA |
Explore the linked device profile
Other records with product code LWR
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
EDWARDS INTUITY Elite Valve System (8300AB)P150036/S081 | Edwards Lifesciences, LLC | PMA supplement | Oct 28, 2026 | FDA |
| ABBOTT MEDICAL | PMA supplement | Sep 18, 2026 | FDA | |
| ABBOTT MEDICAL | PMA supplement | Aug 11, 2026 | FDA | |
EDWARDS INTUITY Elite Valve, Model 8300ABP150036/S080 | Edwards Lifesciences, LLC | PMA supplement | Jul 29, 2026 | FDA |
Avalus BioprosthesisP170006/S045 | Medtronic, Inc. | PMA supplement | Jul 9, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Edwards Lifesciences, LLC
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- One Edwards Way, Irvine, CA, 92614
Sources and methodology
- Original FDA record: P150048/S097
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 21, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records
